rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Allyson J. Ocean

Director

Company insider

Files Form 4 as: Director, NovoCure.

In numbers

Trades disclosed
11
Buys
0
Sells
2
Bought
$0
Sold
$110K
Companies
1
Companies where not an officer
1
First trade
5 Jun 2024
Last trade
3 Jun 2026
Last filed
5 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
NVCR NovoCureDirector · Medical Devices · last 3 Jun 20260 buys · 2 sells

Activity over time

1 Jun 2025 – 1 Oct 2026
10Jun 25Oct 25Feb 26Jun 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
3 Jun 2026filed 5 Jun 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A—11,610 at $0.00filing
3 Jun 2026filed 5 Jun 2026NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A—16,999 at $0.00filing
3 Jun 2026filed 5 Jun 2026NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A—16,999 at $0.00filing
3 Jun 2026filed 5 Jun 2026NVCR NovoCureMedical DevicesSEC FORM 4 Code A—11,610 at $0.00filing
2 Jun 2026filed 3 Jun 2026NVCR NovoCureMedical DevicesSEC FORM 4 Sold$46K2,945 at $15.77filing
2 Jun 2026filed 3 Jun 2026NVCR NovoCureMedical DevicesSEC FORM 4 Sold$46K2,945 at $15.77filing
4 Jun 2025filed 6 Jun 2025NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A—16,697 at $0.00filing
4 Jun 2025filed 6 Jun 2025NVCR NovoCureMedical DevicesSEC FORM 4 Code A—11,215 at $0.00filing
3 Jun 2025filed 4 Jun 2025NVCR NovoCureMedical DevicesSEC FORM 4 Sold$17K999 at $17.29filing
5 Jun 2024filed 6 Jun 2024NVCR NovoCureoption or derivative · Medical DevicesSEC FORM 4 Code A—6,229 at $0.00filing
5 Jun 2024filed 6 Jun 2024NVCR NovoCureMedical DevicesSEC FORM 4 Code A—4,053 at $0.00filing

News

Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NVCR · tickerreport.com · 15 Oct 2026

0 headlines in the last 90 days name Allyson J. Ocean; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Arye Barak BenGeneral Counsel · General Counsel at NovoCure, filing Form 4 there in the last year
Michal Nath PuriChief Human Resources Officer · Chief Human Resources Officer at NovoCure, filing Form 4 there in the last year
Asaf DanzigerDirector · Director at NovoCure, filing Form 4 there in the last year
Frank X. LeonardChief Executive Officer · Chief Executive Officer at NovoCure, filing Form 4 there in the last year
W. Anthony VernonDirector · Director at NovoCure, filing Form 4 there in the last year